BRCA2 and ovarian carcinoma: Exclude substitutions that are likely to create a de novo splice donor within an exon of BRCA1 or BRCA2. Now, from the remaining list of exonic BRCA1/2 gene single‐nucleotide substitutions, identify an algorithmically defined subset of substitutions that confers a statistically significantly increased risk of breast or ovarian cancer.